Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

키워드

참고문헌 (50)

1. Ascha MS, "The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", Hepatology, 51, pp.1972~1978 (2010)
2. Qin J, "A human gut microbial gene catalogue established by metagenomic sequencing", Nature, 464, pp.59~65 (2010)
3. Joseph F. Cavallari, "Intestinal Microbiota Contributes to Energy Balance, Metabolic Inflammation, and Insulin Resistance in Obesity", Journal of Obesity & Metabolic Syndrome, 26(3), pp.161~171 (2017), 대한비만학회
4. Aragonès G, "Gut microbiota-derived mediators as potential markers in nonalcoholic fatty liver disease", Biomed Res Int, 2019, pp.8507583~ (2019)
5. Takiishi T, "Intestinal barrier and gut microbiota: shaping our immune responses throughout life", Tissue Barriers, 5, pp.e1373208~ (2017)
6. Belkaid Y, "Role of the microbiota in immunity and inflammation", Cell, 157, pp.121~141 (2014)
7. Lee NY, "Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome", Gut Microbes, 11, pp.882~899 (2020)
8. Ohtani N, "Role of the gut-liver axis in liver inflammation, fibrosis, and cancer: a special focus on the gut microbiota relationship", Hepatol Commun, 3, pp.456~470 (2019)
9. Saltzman ET, "Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease", Front Microbiol, 9, pp.61~ (2018)
10. Walenbergh SM, "Cholesterol is a significant risk factor for non-alcoholic steatohepatitis", Expert Rev Gastroenterol Hepatol, 9, pp.1343~1346 (2015)
11. Griffin EE, "Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells", J Lipid Res, 46, pp.2052~2060 (2005)
12. Baratta F, "Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease", EBioMedicine, 2, pp.750~754 (2015)
13. 홍이판, "Different Immune Regulatory Potential of Lactobacillus plantarum and Lactobacillus sakei Isolated from Kimchi", Journal of Microbiology and Biotechnology, 24(12), pp.1629~1635 (2014), 한국미생물·생명공학회[DOI]
14. Uchinaka A, "Anti-inflammatory effects of heat-killed Lactobacillus plantarum L-137 on cardiac and adipose tissue in rats with metabolic syndrome", Sci Rep, 8, pp.8156~ (2018)
15. Matuchansky C, "Anti-inflammatory lactobacilli: strain specificity", Gut, 61, pp.786~ (2012)
16. Wong VW, "Treatment of nonalcoholic steatohepatitis with probiotics. A proofof-concept study", Ann Hepatol, 12, pp.256~262 (2013)
17. 백정기, "Can Gut Microbiota Modulation Be Used as a Practical Treatment for Obesity?", Journal of Obesity & Metabolic Syndrome, 27(2), pp.75~77 (2018), 대한비만학회
18. Yoon SH, "Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies", Int J Syst Evol Microbiol, 67, pp.1613~1617 (2017)
19. Edgar RC, "Search and clustering orders of magnitude faster than BLAST", Bioinformatics, 26, pp.2460~2461 (2010)
20. Xie JT, "Antioxidant effects of ginsenoside Re in cardiomyocytes", Eur J Pharmacol, 532, pp.201~207 (2006)
21. Nyblom H, "The AST", ALT ratio as an indicator of cirrhosis in patients with PBC, 2006, pp.26, 840~845
22. Bahl MI, "Freezing fecal samples prior to DNA extraction affects the Firmicutes to Bacteroidetes ratio determined by downstream quantitative PCR analysis", FEMS Microbiol Lett, 329, pp.193~197 (2012)
23. Bugianesi E, "Expanding the natural history of nonalcoholic steatohepatitis:from cryptogenic cirrhosis to hepatocellular carcinoma", Gastroenterology, 123, pp.134~140 (2002)
24. Betrapally NS, "Gut microbiome and liver disease", Transl Res, 179, pp.49~59 (2017)
25. Arguello G, "Recent insights on the role of cholesterol in non-alcoholic fatty liver disease", Biochim Biophys Acta, 1852, pp.1765~1778 (2015)
26. Tomita K, "Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice", Hepatology, 59, pp.154~169 (2014)
27. Liong MT, "Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on highand low-fat diets", Br J Nutr, 98, pp.736~744 (2007)
28. Simons LA, "Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol", Nutr Metab Cardiovasc Dis, 16, pp.531~535 (2006)
29. Tuddenham S, "The intestinal microbiome and health", Curr Opin Infect Dis, 28, pp.464~470 (2015)
30. Ley RE, "Microbial ecology: human gut microbes associated with obesity", Nature, 444, pp.1022~1023 (2006)
31. Schwenger KJ, "The role of the gut microbiome in chronic liver disease: the clinical evidence revised", JHEP Rep, 1, pp.214~226 (2019)
32. Liu C, "Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549", DDP xenograft tumors, 2018, pp.15, 4376~4382
33. Konturek PC, "Gut–liver axis: how do gut bacteria influence the liver?", Med Sci (Basel), 6, pp.79~ (2018)
34. Ma X, "Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells", J Hepatol, 49, pp.821~830 (2008)
35. Park SS, "Lactobacillus acidophilus NS1 attenuates diet-induced obesity and fatty liver", J Endocrinol, 237, pp.87~100 (2018)
36. PARK, YOO HEON, "Effect of Dietary Inclusion of Lactobacillus acidophilus ATCC 43121 onCholesterol Metabolism in Rats", Journal of Microbiology and Biotechnology, 17(4), pp.655~662 (2007), 한국미생물·생명공학회
37. Song M, "Effect of Lactobacillus acidophilus NS1 on plasma cholesterol levels in diet-induced obese mice", J Dairy Sci, 98, pp.1492~1501 (2015)
38. Palaniyandi SA, "Probiotic characterization of cholesterol-lowering Lactobacillus fermentum MJM60397", Probiotics Antimicrob Proteins, 12, pp.1161~1172 (2020)
39. 김병국, "Protective Effect of Lactobacillus fermentum LA12 in an Alcohol-Induced Rat Model of Alcoholic Steatohepatitis", 한국축산식품학회지, 37(6), pp.931~939 (2017), 한국축산식품학회
40. Aronsson L, "Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)", PLoS One, 5, pp.e13087~ (2010)
41. 강다영, "Anti-Obesity Effects of a Mixture of Fermented Ginseng, Bifidobacterium longum BORI, and Lactobacillus paracasei CH88 in High-Fat Diet-Fed Mice", Journal of Microbiology and Biotechnology, 28(5), pp.688~696 (2018), 한국미생물·생명공학회
42. Fuentes MC, "Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults", Br J Nutr, 109, pp.1866~1872 (2013)
43. Li C, "Lactobacillus plantarum NCU116 improves liver function, oxidative stress and lipid metabolism in rats with high fat diet induced non-alcoholic fatty liver disease", Food Funct, 5, pp.3216~3223 (2014)
44. Rinninella E, "What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases", Microorganisms, 7, pp.14~ (2019)
45. Niederreiter L, "Cytokines and fatty liver diseases", Liver Research, 2, pp.14~20 (2018)
46. Caricilli AM, "The role of gut microbiota on insulin resistance", Nutrients, 5, pp.829~851 (2013)
47. You JS, "Commensal-derived metabolites govern Vibrio cholerae pathogenesis in host intestine", Microbiome, 7, pp.132~ (2019)
48. Bogatyrev SR, "Self-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestine", Microbiome, 8, pp.19~ (2020)
49. Guandalini S, "Probiotics for prevention and treatment of diarrhea", J Clin Gastroenterol, 45(Suppl), pp.S149~S153 (2011)
50. Wang J, "Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota", Front Microbiol, 9, pp.1953~ (2018)

관련 논문AI추천